Another busy week for the initial public offering market lies ahead as 10 more companies are scheduled to debut as September's market continues to heat up. The largest deal of the week comes from GoodRx Holdings (NASDAQ: GDRX), which aims to raise over $1.1 billion from about 35 million shares priced in the range of $24-$28 each. The company provides both a mobile app and website that allows prescription drug consumers to compare prices from various sources. The company has demonstrated strong growth and operated in a large market. GoodRX competes with Teladoc (NYSE: TDOC) and Amwell (NYSE: AMWL).
Here's the rest of the companies set to price this week:
Hygo Energy Transition Ltd. (NASDAQ: HYGO) plans to raise over $558 million from roughly 23 million shares priced between $18-$21 each. The Brazilian provider of energy solutions offers integrated downstream liquified natural gas and derives most of its revenue from LNG carriers.
Corsair Gaming, Inc. (NASDAQ: CRSR) aims to raise an offering of about $290 million from 14 million shares priced between $16-$18 each. The computer and gaming hardware supplier is a top pick for high-performance gaming equipment, operating in a $30 billion global market.
BENTLEY SYSTEMS INC (NASDAQ: BSY) is expected to raise about $235 million from roughly 10.8 million shares priced between $17-$19 each. The company provides software for construction and infrastructure projects, operating in a cyclical market. The company has noted that operations were impacted by the coronavirus pandemic. The company competes with Autodesk (NASDAQ: ADSK), Trimble (NASDAQ: TRMB), and Dassault Systems (OTC: DASTY).
Prelude Therapeutics Inc (NASDAQ: PRLD) plans to raise about $182 million from roughly 8.3 million shares priced in the range of $17-$19 each. The clinical-stage oncology biotech has in the past received clearances from the U.S. Food and Drug Administration (F.D.A.) for three new drug applications, advancing those candidates into clinical development, with trials set to launch in early 2021.
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) aims to raise over $151 million from about 6.6 million shares priced between $18-$20 each. The preclinical biotech plans to begin a Phase I/II trial for its lead candidates under a CTA in Canada by the end of this year. The company also plans to submit new drug applications for four different candidates to the F.D.A. by the end of 2021.
GRAYBUG VISION, INC. (NASDAQ: GRAY) plans to offer about $92 million from about 4.7 million shares priced in the range of $15-$17 each. The clinical-stage biopharmaceutical company's lead candidate is currently in a Phase II-b clinical trials, with top line data expected to be reported in the first half of 2021.
Laird Superfood Inc. (NYSE: LSF)plans to raise $42 million from 2.2 million offered shares priced between $18-$20 each. The company manufactures plant-based beverages, generating the majority of its revenue from its Superfood Creamer coffee product. The company's major competitors are Nestle (OTC: NSRGY), Coca-Cola (NYSE: KO) and PepsiCo (NASDAQ: PEP).
Amesite Operating Co (NASDAQ: AMST) plans to raise about $20 million from 3.1 million shares offered between $4.50-$5.50 each. The company provides an AI-driven platform for developing online learning products and software.
PaxMedica Inc. (NASDAQ: PXMD) aims to raise about $15 million from 2.5 million shares priced between $5.50-$6.50 each. The biotech is currently conducting Phase II clinical trials of its lead candidate, with data expected to be reported in early 2021.